Study of a new drug for healthy adults
Treatments studied
This trial tests a new drug called HS-10504 in healthy adults to see how the body processes it. It is an early-phase study that helps determine safe dosing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in good general health.
- You agree to use effective birth control during the study and for 6 months after the last dose.
- You have not used any prescription or over-the-counter medications, herbal supplements, or health products within the last 30 days.
- You do not have significant allergies to similar drugs.
- You do not smoke more than 5 cigarettes a day
- You do not drink alcohol regularly.
- You can avoid smoking, alcohol, caffeine, and certain foods during the study.
- You have not donated blood or lost a significant amount of blood in the last 3 months.
- You are able to attend multiple study visits and follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new drug, SYH2056, in healthy people to see how safe it is and how the body handles it. The study will also look at how food affects the drug. If you are generally healthy, this could be a way to contribute to medical research.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
This study is testing how a new drug is processed by the body in healthy men. It will help researchers understand the drug's effects and safety before it is tested in patients.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This study looks at how the body handles a new investigational drug (HS-10504) in people with liver problems compared to those with healthy liver function.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.